Archives
Tin Mesoporphyrin IX (chloride): Potent Heme Oxygenase Pa...
Tin Mesoporphyrin IX (chloride): A Potent, Nanomolar Heme Oxygenase Inhibitor for Research Applications
Executive Summary: Tin Mesoporphyrin IX (chloride) is a highly potent, competitive inhibitor of heme oxygenase (HO) activity with a Ki of 14 nM for rat splenic microsomal HO in vitro (APExBIO). It achieves robust inhibition of hepatic, renal, and splenic HO in vivo at doses as low as 1 pmol/kg, leading to effective reduction in serum bilirubin in neonatal and hyperbilirubinemic animal models. This inhibitor enables dissecting the heme degradation pathway, a key regulator of oxidative stress and metabolic disease (Koyaweda et al., 2026). Tin Mesoporphyrin IX (chloride) is a crystalline solid, stable at -20°C, with recommended use in short-term solution (APExBIO). No clinical trials are published; research use only.
Biological Rationale
Heme oxygenase (HO) catalyzes the degradation of heme to biliverdin, carbon monoxide, and ferrous iron. HO-1, the inducible isoform, is upregulated by oxidative stress and inflammation. Activation of HO-1 has been shown to modulate intracellular reactive oxygen species (ROS) and impact viral replication cycles, such as in hepatitis B virus (HBV) infection (Koyaweda et al., 2026). Inhibiting HO activity is essential for studying the role of heme catabolism in metabolic disease, insulin resistance, metaflammation, and bilirubin metabolism. Tin Mesoporphyrin IX (chloride), as a potent HO inhibitor, enables precise control over this pathway for mechanistic research (Related Article – this article extends the discussion with new in vivo details).
Mechanism of Action of Tin Mesoporphyrin IX (chloride)
Tin Mesoporphyrin IX (chloride), also known as SnMP, is a metalloporphyrin analog that competitively binds to the heme-binding site of HO enzymes. This binding prevents the enzymatic conversion of heme to biliverdin, thereby inhibiting the production of downstream metabolites including bilirubin and carbon monoxide (APExBIO). The inhibition constant (Ki) for rat splenic microsomal HO is 14 nM, indicating high affinity in vitro. In vivo, administration of SnMP at 1 pmol/kg effectively suppresses hepatic, renal, and splenic HO activity. This suppression leads to reduced serum bilirubin levels, especially relevant in neonatal and hyperbilirubinemic animal models (Related Article – this article clarifies dose-response parameters and solution stability vs. existing summaries).
- Competitive inhibition: SnMP directly competes with heme for the active site of HO enzymes.
- Downstream effects: Prevents production of biliverdin, CO, and iron; alters cellular redox state and signaling.
- Prolonged biological effect: Maintains heme saturation of hepatic tryptophan pyrrolase, sustaining pathway inhibition.
Evidence & Benchmarks
- Tin Mesoporphyrin IX (chloride) exhibits a Ki of 14 nM against rat splenic microsomal HO in vitro (APExBIO).
- Doses as low as 1 pmol/kg body weight inhibit hepatic, renal, and splenic HO activity in vivo (APExBIO).
- SnMP reduces serum bilirubin in neonatal and hyperbilirubinemic animal models (APExBIO).
- HO-1 is a critical mediator of oxidative stress and viral replication; modulating HO-1 can alter HBV morphogenesis (Koyaweda et al., 2026).
- SnMP maintains stability as a crystalline solid stored at -20°C; solutions are recommended for short-term use only (APExBIO).
- Solubility profile: up to 0.5 mg/ml in DMSO, 1 mg/ml in dimethyl formamide (APExBIO).
Applications, Limits & Misconceptions
Tin Mesoporphyrin IX (chloride) is used in:
- Heme oxygenase activity assays in vitro and in vivo
- Metabolic disease research, including insulin resistance and metaflammation models
- Studies of bilirubin metabolism and hyperbilirubinemia
- Dissecting the heme oxygenase signaling pathway in oxidative stress and viral pathogenesis (Strategic HO Research – this article updates mechanistic and translational guidance)
Common Pitfalls or Misconceptions
- SnMP is not approved for diagnostic or therapeutic human use; research use only.
- Efficacy and pharmacokinetics are species-specific; extrapolation to humans is not validated.
- Long-term solution stability is limited; use freshly prepared solutions for reproducible results.
- Inhibition is competitive, not irreversible; excess heme can overcome inhibition in vitro.
- No published clinical trials; data are restricted to preclinical and animal models.
Workflow Integration & Parameters
- Formulation: Crystalline solid; solubility up to 0.5 mg/ml in DMSO, 1 mg/ml in dimethyl formamide.
- Storage: Store at -20°C. Use solutions immediately; minimize freeze-thaw cycles.
- Dose selection: In vivo inhibition observed at 1 pmol/kg in rodent models. Titrate for species- and tissue-specific applications.
- Controls: Include vehicle and heme-only controls to confirm competitive inhibition.
- Assay compatibility: Validated for in vitro and in vivo HO activity assays (Advanced Tool – this article provides additional protocol troubleshooting advice).
For detailed product characteristics, consult the official APExBIO page for Tin Mesoporphyrin IX (chloride) (SKU C5606).
Conclusion & Outlook
Tin Mesoporphyrin IX (chloride) is a benchmark, potent heme oxygenase inhibitor offering precise pathway modulation for metabolic, oxidative, and viral disease research. Its nanomolar affinity, proven in vivo efficacy, and well-characterized solubility and storage parameters make it a premier tool for preclinical investigation. While no clinical results are reported, SnMP remains central for mechanistic studies of HO-1-mediated processes and for developing new interventions targeting heme degradation and associated signaling pathways.